Montelukast Sodium Tablet, Chewable
Product Images NDC 62175-204

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 62175-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)

A line graph showing change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The horizontal axis represents weeks from -19 to 56, and the vertical axis shows height change from -3 to 7 cm. Each treatment group is represented with a distinct line and marker.*

FDA Label Image

Chemical Structure (Montelukast Sodium Tablets And Chewable Tablets 2)

Chemical structure of Montelukast Sodium, depicting the molecular arrangement including aromatic rings, a chlorine atom, sulfur, and a sodium carboxylate group.*

FDA Label Image

Figure 2 (Montelukast Sodium Tablets And Chewable Tablets 3)

A line graph illustrating mean percent change from baseline over weeks in treatment comparing Montelukast Sodium and placebo groups, with data points from baseline to week 15 including a washout period. Montelukast Sodium shows a higher increase compared to placebo.*

FDA Label Image

4 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 4)

Montelukast Sodium 4 mg chewable tablets label from Lannett Company, Inc. The label indicates the tablets are for pediatric patients aged 2-5 years. It includes storage instructions, dosage form, quantity of 90 tablets, and a barcode along the right side.*

FDA Label Image

5 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 5)

Montelukast Sodium 5 mg chewable tablets label. The label states the tablets are for pediatric patients aged 6-14 years and contain 5 mg montelukast sodium equivalent to 5 mg montelukast. It is distributed by Lannett Company, Inc., Philadelphia, PA, and includes storage instructions and a barcode. The package contains 90 tablets.*

FDA Label Image

10 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 6)

Montelukast Sodium Tablets 10 mg chewable tablets label from Lannett Company, Inc. This prescription drug for oral administration is indicated for adults 15 years and older, with 90 tablets per container. The label includes dosage information, storage instructions, distributor details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.